Nongshim Partners with Chinese Company to Launch Collagen Supplements in China
South Korean instant noodle maker teams up with Guangzhou Wanglaoji Pharmaceutical to expand into dietary supplements market
Quick Look
- Nongshim Co., South Korea's leading instant noodle maker, has partnered with Guangzhou Wanglaoji Pharmaceutical Co. to launch collagen-based dietary supplements in China during the second half of 2026.
- Under the agreement, Nongshim will sell its Lifill collagen products through the Chinese company's distribution network, while also planning to introduce partner supplements in the Korean market later this year.
- China's dietary supplements market is valued at approximately 41 trillion won ($27.8 billion), with expected 7% annual growth through 2027.
AI-generated summary
SEOUL, April 29 (Yonhap) -- Nongshim Co., South Korea's leading instant noodle maker, said Wednesday it has partnered with a Chinese company to launch collagen-based dietary supplements in the second half of the year. Under the agreement, Nongshim will sell its Lifill collagen products through the distribution network of Guangzhou Wanglaoji Pharmaceutical Co. in China, the company said in a press release. Nongshim also plans to introduce its partner's dietary supplements in the Korean market later this year to create synergies. China's dietary supplements market, valued at about 41 trillion won (US$27.8 billion), is expected to grow at an average annual rate of around 7 percent through 2027, the company said. The partnership is part of Nongshim's broader effort to diversify its portfolio beyond instant noodles and snacks and secure long-term growth.
